Generations for Heart Health
Public ClinicalTrials.gov record NCT07901439. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
3-2-GenHealth: A Familism-Informed Pilot to Engage Mothers and Grandmothers in Cardiovascular Research and Prevention
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Heart disease is the leading cause of death for women in the United States, and many women find it hard to prioritize their own health while caring for family. This randomized control trial pilot aims to test whether linking heart-healthy habits to a woman's role as a mother or grandmother can increase physical activity and improve other heart-healthy behaviors. The study will enroll mothers and grandmothers of young children, who may join as a mother-grandmother pair or on their own. All participants will complete a baseline questionnaire (self-reported cardiovascular health including physical activity), followed by 4 weeks of wearing an activity tracker (such as a Fitbit) and a post-study period questionnaire (repeating baseline measures). After the first baseline week, participants will be randomly assigned, with pairs assigned together, to an intervention or comparison group. The intervention group will complete a short online writing activity about their caregiving role and personal values, then receive 2 weeks of daily text messages linking their health and physical activity to the health of their children and family, followed by a fourth observational week where no messaging is delivered. The comparison group will also wear the tracker for 4 weeks, but will receive 2 weeks of general daily messages (a greeting + device use reminder). The main question is whether the intervention group is more engaged in the study activities during the text message period.
Study identification
- NCT ID
- NCT07901439
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 1, 2026 (Estimated)
- Primary completion
- Dec 31, 2027 (Estimated)
- Completion
- Dec 31, 2027 (Estimated)
- Last update posted
- Oct 28, 2026
2026 – 2027
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| NYU Langone Health | Long Island City | New York | 11101 | — |
| NYU Langone Health | New York | New York | 10016 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07901439, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 28, 2026 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07901439 live on ClinicalTrials.gov.